Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)LeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Beam Therapeutics (BEAM) Depreciation & Amortization (IS) (2024 - 2025)

Beam Therapeutics (BEAM) has disclosed Depreciation & Amortization (IS) for 2 consecutive years, with $5.7 million as the latest value for Q4 2025.

  • Quarterly Depreciation & Amortization (IS) rose 4.13% to $5.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $22.3 million through Dec 2025, up 1.68% year-over-year, with the annual reading at $22.3 million for FY2025, 1.68% up from the prior year.
  • Depreciation & Amortization (IS) for Q4 2025 was $5.7 million at Beam Therapeutics, up from $5.6 million in the prior quarter.
  • The five-year high for Depreciation & Amortization (IS) was $5.7 million in Q4 2025, with the low at $5.4 million in Q1 2024.